Graf Akcie ARWR (Arrowhead Pharmaceuticals Inc.). Diskuze k akciím ARWR. Aktuální informace ARWR.

Základní informace o společnosti Arrowhead Pharmaceuticals Inc. (Akcie ARWR)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 6.96B
Hodnota podniku (EV) 5.99B
Tržby 107.638M
EBITDA -126.74
Zisk -125.91
Růst v tržbách Q/Q 67.63 %
Růst v tržbách Y/Y -12.95 %
P/E (Cena vůči ziskům) N/A
Forward P/E -799.49
EV/Sales 55.61
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 64.62
P/FCF 41.59
Price/Book 15.06
Účetní hodnota na akcii 4.45
Hotovost na akcii 3.04
FCF vůči ceně 2.40 %
Počet zaměstnanců 232
Tržba na zaměstnance 463.956k
Profit margin -96.09 %
Operating margin -124.75 %
Gross margin 100.00 %
EBIT margin -121.10 %
EBITDA margin -117.74 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 123.08 %
EPS - Očekávaný růst příští rok -79.17 %
Return on assets -20.04 %
Return on equity -28.00 %
ROIC -21.48 %
ROCE -24.16 %
Dluhy/Equity 0.13
Čistý dluh/EBITDA 12.82
Current ratio 2.69
Quick Ratio 2.69
Volatilita 3.58
Beta 1.24
RSI 61.58
Cílová cena analytiků 78
Známka akcie (dle analytiků) 1.30
Insider ownership 3.20 %
Institutional ownership 67.41 %
Počet akcií 104.259M
Procento shortovaných akcií 3.91 %
Short ratio 3.22 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2000
Země United States

Finanční výsledky akcie ARWR

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$87.992$168.796$16.142$31.408$0.158$0.382
Cost Of Goods Sold------
Gross Profit$87.992$168.796$16.142$31.408$0.158$0.382
Research And Development Expenses$128.875$81.049$52.969$50.905$62.118$47.267
SG&A Expenses$52.276$26.556$19.11$17.499$23.595$34.718
Other Operating Income Or Expenses----$3.812$-1.892
Operating Expenses$181.151$107.605$72.079$68.404$81.901$96.356
Operating Income$-93.159$61.191$-55.936$-36.996$-81.743$-95.974
Total Non-Operating Income/Expense$8.608$6.958$1.488$2.618$0.022$4.036
Pre-Tax Income$-84.551$68.148$-54.448$-34.378$-81.721$-91.939
Income Taxes$0.002$0.174$0.002$0.002$-0.002$-0.002
Income After Taxes$-84.553$67.975$-54.451$-34.38$-81.718$-91.936
Other Income------
Income From Continuous Operations$-84.553$67.975$-54.451$-34.38$-81.718$-91.936
Income From Discontinued Operations------
Net Income$-84.553$67.975$-54.451$-34.38$-81.723$-91.941
EBITDA$-86.691$66.699$-50.854$-32.349$-78.251$-92.527
EBIT$-93.159$61.191$-55.936$-36.996$-81.743$-95.974
Basic Shares Outstanding1019484746157
Shares Outstanding1019984746157
Basic EPS$-0.84$0.72$-0.65$-0.47$-1.34$-1.60
EPS - Earnings Per Share$-0.84$0.69$-0.65$-0.47$-1.34$-1.60
# 2020 2019 2018 2017 2016 2015
Current Ratio7.92432.73256.37033.6313.52926.4697
Long-term Debt / Capital--0.02160.02790.0260.0049
Debt/Equity Ratio--0.02440.03130.02870.0069
Gross Margin100100100100100100
Operating Margin-105.871836.2513-346.5192-117.7924-51627.09-25124.08
EBIT Margin-105.871836.2513-346.5192-117.7924-51627.09-25124.08
EBITDA Margin-98.521739.5146-315.0345-102.997-49421.64-24221.79
Pre-Tax Profit Margin-96.089240.3733-337.3002-109.4569-51613.12-24067.67
Net Profit Margin-96.091940.2705-337.3151-109.4645-51614.64-24068.29
Asset Turnover0.16840.48250.14460.30190.00120.0029
Inventory Turnover Ratio------
Receiveable Turnover104.0498255.224649.3084463.2612.1111-
Days Sales In Receivables3.50791.43017.40240.7879172.8951-
ROE - Return On Equity-18.310327.8544-57.1713-42.5145-85.9972-83.8667
Return On Tangible Equity-18.940529.9485-71.1985-56.9185-112.1583-108.4184
ROA - Return On Assets-16.182319.43-48.7864-33.0509-63.7544-69.5075
ROI - Return On Investment-18.310327.8544-55.9372-41.3264-83.764-83.455
Book Value Per Share4.51062.55521.07611.08131.36241.8409
Operating Cash Flow Per Share-2.70192.3194-0.24070.73140.0903-0.391
Free Cash Flow Per Share-2.69882.2147-0.15050.68740.0614-0.3889